Jordi Llop received his degree in chemistry from Ramon Llull University, Barcelona, Spain, in 1996, and his degree in chemical engineering from Institut Quimic de Sarria, Barcelona, Spain, in 1997. Between 1998 and 2002 he worked on his Ph.D. at Barcelona Material Sciences Institute (ICMAB-CSIC), getting his Ph.D. degree at Ramon Llull University in 2002. In 2002, he worked as a Postdoctoral Researcher at the Radiopharmaceutical Lab, PET Center, Navarra University Hospital (CUN), Pamplona, Spain, and in 2003 at PET Center, Uppsala University, Uppsala, Sweden. In 2004, he went back to Spain to work as Production Manager of the Radiopharmaceutical Laboratory, Institut d’Alta Tecnologia (IAT-PRBB, Barcelona) and Responsible of the Radiochemistry and Chemistry Department. He was leading projects regarding the production of new radiotracers for preclinical and clinical experiments. During this period, he was Associate Professor at Pompeu Fabra University, Barcelona, Spain. In October 2007, he moved to CIC biomaGUNE as a Group Leader in Radiochemistry and Radioprotection Officer. Since 2011, he is the Head of the Radiochemistry Department and Member of the Scientific Committee of CIC biomaGUNE. He is expert in the development of new radioisotopes production in a PET cyclotron, labelling molecules with 18F, 11C, 13N, and 68Ga and in the design of studies using molecular imaging techniques (PET, SPECT, and MRI). He is Reviewer of some international journals such us ACS Nano, Bioorganic and Medicinal Letters, and Journal of Labelled Compounds and Radiopharmaceuticals.
Biography Updated on 22 August 2013